Abstract 910P
Background
Parotid mucoepidermoid carcinoma (P-MEC) is a major histopathological subtype of salivary gland cancer, characterized by heterogeneity and complexity. Traditional clinical models and treatment plans are limited in providing personalized treatment recommendations and clinical management. This study aims to develop a machine learning-based prognostic model to improve survival rate prediction accuracy for P-MEC patients.
Methods
We used SEER database data (2004-2015) for 882 postoperative P-MEC patients. Single-factor Cox regression and four machine learning algorithms (Random Forest, LASSO, XGBoost, Best Subset Regression) were employed for variable selection and importance evaluation. The optimal variable selection model was determined using stepwise backward regression, AIC, and AUC. Bootstrap resampling was applied for internal validation.The model's prediction accuracy was assessed through C-index, ROC curve, and calibration curve. The clinical utility of the model was evaluated via DCA.
Results
The 3-, 5-, and 10-year OS rates for postoperative P-MEC patients were 0.887, 0.841, and 0.753. XGBoost, BSR, and LASSO demonstrated good predictive performance in variable selection and identified 7 independent prognostic factors: age, pathological grade, T stage, N stage, radiation therapy, chemotherapy, and marital status. A nomogram was developed based on the identified predictive variables. Internal validation with 1000 bootstrap resamples yielded consistent results for C-index (3-year, 0.841, 95%CI=0.839-0.844; 5-year, 0.842, 95%CI=0.840-0.845) and AUC (3-year, 0.858, 95%CI=0.856-0.860; 5-year, 0.872, 95%CI=0.870-0.875). The calibration plot indicated good prediction fit.
Conclusions
This study identified age, pathological grade, T stage, N stage, radiation therapy, chemotherapy, and marital status as independent prognostic factors in postoperative P-MEC patients. Machine learning algorithms outperformed traditional analysis methods in variable selection, predictive performance, and variable importance visualization. The developed machine learning-based nomogram offers high accuracy, robust calibration, and clinical application value for postoperative P-MEC patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
868P - A DNA methylation classifier to predict recurrence from clear surgical margins
Presenter: tsima Abou Kors
Session: Poster session 12
869P - Utilizing H&E images and digital pathology to predict response to buparlisib in SCCHN
Presenter: Denis Soulieres
Session: Poster session 12
870P - Dynamic cfHPV DNA changes during induction chemotherapy as an early indicator of treatment responsiveness for locally advanced head and neck cancer patients
Presenter: Yilin Cao
Session: Poster session 12
871P - Detection of circulating tumor DNA in operable loco-regionally advanced HPV-negative head and neck squamous cell carcinoma
Presenter: Ludivine Beaussire
Session: Poster session 12
872P - Prognostic value of pathological intratumor heterogeneity in patients with head and neck squamous cell carcinoma treated with upfront surgery
Presenter: Constance Lamy
Session: Poster session 12
873P - Identification of PIK3CA mutation as a novel predictor of efficacious immunotherapy in head and neck cancer
Presenter: Zongwen Sun
Session: Poster session 12
875P - Proteomic and phosphoproteomic profiling of HNSCC and the role of CDKs as potential drug targets
Presenter: Konrad Klinghammer
Session: Poster session 12
876P - Gene expression analysis in oral potentially malignant disorders (OPMD) with dysplasia identifies patients at high risk of malignant transformation
Presenter: Loris De Cecco
Session: Poster session 12
877P - ROS1 mutations as potential negative predictor for response of immunotherapy in patient with head and neck cancer
Presenter: Yong Yuan
Session: Poster session 12